Literature DB >> 32557839

Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension.

Vincenzo Donadio1, Alex Incensi1, Giovanni Rizzo1,2, Rosa De Micco3, Alessandro Tessitore3, Grazia Devigili4, Francesca Del Sorbo5, Salvatore Bonvegna5, Rossella Infante1, Martina Magnani1, Corrado Zenesini1, Luca Vignatelli1, Roberto Cilia5, Roberto Eleopra4, Gioacchino Tedeschi3, Rocco Liguori1,2.   

Abstract

BACKGROUND: The differential diagnosis between multiple system atrophy parkinsonism type (MSA-P) and Parkinson's disease with orthostatic hypotension (PD+OH) is difficult because the 2 diseases have a similar clinical picture. The aim of this study is to distinguish MSA-P from PD+OH by immunostaining for abnormal phosphorylated α-synuclein at serine 129 (p-syn) in cutaneous nerves.
METHOD: We recruited 50 patients with parkinsonism and chronic orthostatic hypotension: 25 patients fulfilled the diagnostic criteria for MSA-P and 25 patients for PD+OH. The patients underwent a skin biopsy from the cervical area, thigh, and leg to analyze somatic and autonomic skin innervation and p-syn in skin nerves.
RESULTS: Intraneural p-syn positivity was found in 72% of patients with MSA-P, mainly in distal skin sites. More important, p-syn deposits in MSA-P differed from PD+OH because they were mainly found in somatic fibers of subepidermal plexi, whereas scant autonomic fiber involvement was found in only 3 patients. All patients with PD+OH displayed widely distributed p-syn deposits in the autonomic skin fibers of proximal and distal skin sites, whereas somatic fibers were affected only slightly in 4 patients with PD+OH. Skin innervation mirrored p-syn deposits because somatic innervation was mainly reduced in MSA-P. Sympathetic innervation was damaged in PD+OH but fairly preserved in MSA-P.
CONCLUSIONS: The p-syn in cutaneous nerves allows the differentiation of MSA-P from PD+OH; MSA-P mainly shows somatic fiber involvement with relatively preserved autonomic innervation; and by contrast, PD+OH displays prevalent abnormal p-syn deposits and denervation in autonomic postganglionic nerves.
© 2020 International Parkinson and Movement Disorder Society. © 2020 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  misfolded alpha-synuclein; multiple system atrophy; orthostatic hypotension; parkinsonism; skin biopsy

Mesh:

Substances:

Year:  2020        PMID: 32557839     DOI: 10.1002/mds.28126

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  15 in total

1.  Postganglionic Sudomotor Assessment in Early Stage of Multiple System Atrophy and Parkinson Disease: A Morpho-functional Study.

Authors:  Vincenzo Provitera; Valeria Iodice; Fiore Manganelli; Stefania Mozzillo; Giuseppe Caporaso; Annamaria Stancanelli; Ilaria Borreca; Marcello Esposito; Raffaele Dubbioso; Rosa Iodice; Floriana Vitale; Shiwen Koay; Ekawat Vichayanrat; Fernanda Valerio; Lucio Santoro; Maria Nolano
Journal:  Neurology       Date:  2022-01-11       Impact factor: 9.910

2.  Responsiveness of UMSARS and other clinical measures in a longitudinal structured care clinic for multiple system atrophy.

Authors:  Elisabeth P Golden; Morgan McCreary; Steven Vernino
Journal:  Clin Auton Res       Date:  2022-10-01       Impact factor: 5.625

3.  A case series of cutaneous phosphorylated α-synuclein in Long-COVID POTS.

Authors:  Mitchell G Miglis; Jordan Seliger; Ruba Shaik; Christopher H Gibbons
Journal:  Clin Auton Res       Date:  2022-05-16       Impact factor: 5.625

4.  Cardiac 18F-Dopamine PET Distinguishes PD with Orthostatic Hypotension from Parkinsonian MSA.

Authors:  Abhishek Lenka; Guillaume Lamotte; David S Goldstein
Journal:  Mov Disord Clin Pract       Date:  2021-03-23

5.  In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC.

Authors:  Vincenzo Donadio; Zerui Wang; Alex Incensi; Giovanni Rizzo; Enrico Fileccia; Veria Vacchiano; Sabina Capellari; Martina Magnani; Cesa Scaglione; Michelangelo Stanzani Maserati; Patrizia Avoni; Rocco Liguori; Wenquan Zou
Journal:  Neurology       Date:  2021-04-09       Impact factor: 11.800

Review 6.  Genetic Diversity of SARS-CoV2 and Environmental Settings: Possible Association with Neurological Disorders.

Authors:  Sharifa Hasana; Md Farhad Hossain; Maroua Jalouli; Md Tanvir Kabir; Md Giash Uddin; Mir Imam Ibne Wahed; Tapan Behl; May N Bin-Jumah; Mohamed M Abdel-Daim; Lotfi Aleya; Md Sahab Uddin
Journal:  Mol Neurobiol       Date:  2021-01-06       Impact factor: 5.590

Review 7.  Neuropathology and molecular diagnosis of Synucleinopathies.

Authors:  Shunsuke Koga; Hiroaki Sekiya; Naveen Kondru; Owen A Ross; Dennis W Dickson
Journal:  Mol Neurodegener       Date:  2021-12-18       Impact factor: 14.195

8.  Alpha-synuclein oligomers and small nerve fiber pathology in skin are potential biomarkers of Parkinson's disease.

Authors:  Elena Vacchi; Camilla Senese; Giacomo Chiaro; Giulio Disanto; Sandra Pinton; Sara Morandi; Ilaria Bertaina; Giovanni Bianco; Claudio Staedler; Salvatore Galati; Claudio Gobbi; Alain Kaelin-Lang; Giorgia Melli
Journal:  NPJ Parkinsons Dis       Date:  2021-12-20

Review 9.  Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder.

Authors:  Mitchell G Miglis; Charles H Adler; Elena Antelmi; Dario Arnaldi; Luca Baldelli; Bradley F Boeve; Matteo Cesari; Irene Dall'Antonia; Nico J Diederich; Kathrin Doppler; Petr Dušek; Raffaele Ferri; Jean-François Gagnon; Ziv Gan-Or; Wiebke Hermann; Birgit Högl; Michele T Hu; Alex Iranzo; Annette Janzen; Anastasia Kuzkina; Jee-Young Lee; Klaus L Leenders; Simon J G Lewis; Claudio Liguori; Jun Liu; Christine Lo; Kaylena A Ehgoetz Martens; Jiri Nepozitek; Giuseppe Plazzi; Federica Provini; Monica Puligheddu; Michal Rolinski; Jan Rusz; Ambra Stefani; Rebekah L S Summers; Dallah Yoo; Jennifer Zitser; Wolfgang H Oertel
Journal:  Lancet Neurol       Date:  2021-08       Impact factor: 44.182

Review 10.  Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson's Disease.

Authors:  Kathrin Doppler
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.